Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
The Lancet Regional Health. Europe|December 12, 2022
Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 monthsSnehal M Pinto Pereira, Roz Shafran, Manjula D Nugawela, et al.
Children (Basel, Switzerland)|July 29, 2023
Symptom Profiles of Children and Young People 12 Months after SARS-CoV-2 Testing: A National Matched Cohort Study (The CLoCk Study)Snehal M Pinto Pereira, Manjula D Nugawela, Kelsey McOwat, et al.
Journal of Medical Internet Research|January 28, 2025
Health and Experiences During the COVID-19 Pandemic Among Children and Young People: Analysis of Free-Text Responses From the Children and Young People With Long COVID StudyNatalia K Rojas, Sam Martin, Mario Cortina-Borja, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 5, 2024
Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP studyRuth Simmons, Annabel A Powell, Samreen Ijaz, et al.
The International Journal on Drug Policy|June 28, 2024
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UKPantelis Samartsidis, Ross J Harris, John Dillon, et al.
The New England Journal of Medicine|July 21, 2021
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantJamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
Brain, Behavior, and Immunity|May 12, 2024
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant)Paul Foret-Bruno, Roz Shafran, Terence Stephenson, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The New England Journal of Medicine|January 12, 2022
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesNick Andrews, Elise Tessier, Julia Stowe, et al.
Pageof 10